Rule 15c3-4 requires OTC derivatives
dealers to establish and document a risk management control system.
In addition, the Rule establishes basic principles and minimum
standards governing the creation, execution, and review of a firm's
risk management control system. These principles and standards are
designed to ensure the integrity of the risk measurement,
monitoring, and management process.
US Code:
15
USC 78o Name of Law: Securities Exchange Act of 1934
The increase in burden hours is
due to an increase in the estimated number of registrants subject
to the rule. The Commission now estimates that a total of nine
entities will be registered as OTC derivatives dealers at the end
of the next three years, consisting of the three current OTC
derivatives dealers, and six anticipated registrants (in contrast
with the prior estimate of six OTC derivatives dealers, consisting
of four current OTC derivatives dealers and two anticipated
registrants).
$49,896
No
No
No
No
No
No
Uncollected
Abraham Jacob 202
551-5583
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.